Question

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

4
5
Total Forecasters42
Community Prediction
67%
(59% - 75%)

Make a Prediction

50%
community: 67%
No key factors yetAdd some that might influence this forecast.
Add key factor
Authors:
casens
Opened:Nov 24, 2021
Closes:Jan 1, 2029
Scheduled resolution:Jan 1, 2029
Spot Scoring Time:Nov 26, 2021
Health & Pandemics